PRESS RELEASE published on 01/23/2023 at 13:45, 3 years ago Amarc's Extensive Surface Surveys Identify and Expand Porphyry Copper-Gold Deposit Drill Targets across the Joy Copper-Gold District
PRESS RELEASE published on 01/19/2023 at 13:45, 3 years 1 month ago Drilling Recommences at Amarc's Duke Copper-Gold District, BC
PRESS RELEASE published on 01/18/2023 at 13:45, 3 years 1 month ago Visit Amarc at Three Conferences in Vancouver this Month
PRESS RELEASE published on 01/17/2023 at 13:45, 3 years 1 month ago Amarc 2022 a Transformative Year and Corporate Outlook
Published on 02/21/2026 at 00:45, 1 day 19 hours ago Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 1 day 19 hours ago Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:00, 1 day 20 hours ago Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 1 day 21 hours ago Organto Foods Completes Warrant Exercise Incentive Program
Published on 02/22/2026 at 12:19, 7 hours 37 minutes ago Elmos Semiconductor SE: Generational change initiated in the Supervisory Board
Published on 02/22/2026 at 10:09, 9 hours 47 minutes ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 02/21/2026 at 12:00, 1 day 7 hours ago Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Published on 02/21/2026 at 12:00, 1 day 7 hours ago Abivax présente, au Congrès de l’ECCO 2026, les premières preuves d’une activité antifibrotique d'obefazimod, ainsi que de nouvelles analyses de son efficacité et de sécurité dans les MICI
Published on 02/20/2026 at 18:36, 2 days 1 hour ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
